AZD0156 enhances radiation-induced tumour growth inhibition, potentiates PARP inhibitors like olaparib, and shows synergistic effects with irinotecan, demonstrating promise in combinatorial cancer therapies276,.277. The gene discussed is PARP1; the disease is cancer.